Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,558 | 152 | 99.6% |
| Education | $11.02 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $418.70 | 27 | $0 (2020) |
| Lilly USA, LLC | $397.76 | 18 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $341.17 | 27 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $319.92 | 15 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $220.19 | 17 | $0 (2019) |
| Astellas Pharma US Inc | $139.43 | 7 | $0 (2019) |
| PFIZER INC. | $134.48 | 7 | $0 (2019) |
| AbbVie, Inc. | $131.80 | 7 | $0 (2019) |
| Orexigen Therapeutics, Inc. | $59.17 | 4 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $51.75 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $39.37 | 2 | Abbott Laboratories ($25.96) |
| 2020 | $70.46 | 4 | AstraZeneca Pharmaceuticals LP ($39.77) |
| 2019 | $580.15 | 26 | Lilly USA, LLC ($210.49) |
| 2018 | $655.47 | 35 | AstraZeneca Pharmaceuticals LP ($138.97) |
| 2017 | $1,224 | 87 | AstraZeneca Pharmaceuticals LP ($207.94) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/03/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: VACCINES | ||||||
| 01/13/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Neuromodulation | ||||||
| 04/02/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Respiratory | ||||||
| 03/05/2020 | Seqirus USA Inc | Fluad (Biological), FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Vaccines | ||||||
| 02/20/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 01/09/2020 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Respiratory | ||||||
| 12/12/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular | ||||||
| 10/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Endocrinology | ||||||
| 09/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $98.00 | General |
| Category: Diabetes | ||||||
| 09/24/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes | ||||||
| 09/24/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Diabetes | ||||||
| 09/13/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: DIABETES | ||||||
| 08/22/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/01/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Neuroscience | ||||||
| 07/25/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: UROLOGY | ||||||
| 06/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/30/2019 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Diabetes | ||||||
| 05/16/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Respiratory | ||||||
| 05/14/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: VACCINE | ||||||
| 04/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 14 | 800 | 921 | $187,986 | $64,701 |
| 2021 | 18 | 1,206 | 1,416 | $268,430 | $95,277 |
| 2020 | 10 | 375 | 430 | $108,646 | $28,913 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 224 | 340 | $108,800 | $28,757 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 84 | 84 | $25,704 | $11,179 | 43.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 52 | 52 | $14,040 | $8,848 | 63.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $5,040 | $4,454 | 88.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 57 | $13,110 | $2,790 | 21.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 140 | 140 | $8,120 | $2,678 | 33.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 89 | 89 | $4,717 | $1,664 | 35.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $1,632 | $1,594 | 97.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 23 | 23 | $2,300 | $926.87 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $2,054 | $791.15 | 38.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 23 | $805.00 | $698.10 | 86.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 19 | $684.00 | $182.67 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $845.00 | $105.30 | 12.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 15 | $135.00 | $33.34 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 206 | 341 | $109,120 | $31,116 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 152 | 152 | $46,512 | $20,885 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 167 | 238 | $54,740 | $15,725 | 28.7% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 30 | 30 | $10,560 | $7,163 | 67.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 162 | 162 | $9,396 | $3,164 | 33.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 47 | 47 | $3,196 | $3,050 | 95.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 146 | 146 | $7,738 | $2,851 | 36.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 36 | 36 | $6,480 | $2,793 | 43.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 15 | 15 | $4,050 | $2,434 | 60.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $1,860 | $1,493 | 80.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 35 | 35 | $3,500 | $1,434 | 41.0% |
About Dr. Lydia Jeffcoat, MD
Dr. Lydia Jeffcoat, MD is a Internal Medicine healthcare provider based in Newburyport, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699874495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lydia Jeffcoat, MD has received a total of $2,569 in payments from pharmaceutical and medical device companies, with $39.37 received in 2022. These payments were reported across 154 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,558).
As a Medicare-enrolled provider, Jeffcoat has provided services to 2,381 Medicare beneficiaries, totaling 2,767 services with total Medicare billing of $188,892. Data is available for 3 years (2020–2022), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Newburyport, MA
- Active Since 09/21/2006
- Last Updated 08/13/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699874495
Products in Payments
- TRULICITY (Drug) $293.60
- SYMBICORT (Drug) $233.57
- INVOKANA (Drug) $183.29
- JARDIANCE (Drug) $173.31
- XARELTO (Drug) $151.86
- JANUVIA (Drug) $122.49
- BEVESPI AEROSPHERE (Drug) $107.25
- Myrbetriq (Drug) $85.11
- SPIRIVA RESPIMAT (Drug) $81.87
- CHANTIX (Drug) $76.21
- Trintellix (Drug) $75.00
- STIOLTO (Drug) $68.79
- FARXIGA (Drug) $64.66
- CONTRAVE (Drug) $59.17
- EMGALITY (Drug) $58.77
- NUEDEXTA (Drug) $51.75
- Xofluza (Drug) $43.47
- ZOSTAVAX (Biological) $38.64
- ELIQUIS (Drug) $38.34
- Prolia (Biological) $34.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newburyport
Dr. Michael Mccartney, M.d, M.D
Internal Medicine — Payments: $53,704
Houtan Golzari, M.d, M.D
Internal Medicine — Payments: $18,905
Shih-Te Wen, Md, MD
Internal Medicine — Payments: $9,328
Dr. Julie Geary, Md, MD
Internal Medicine — Payments: $6,743
Dr. Anthony Eaton, M.d, M.D
Internal Medicine — Payments: $4,029
Saira Naseer, Md, MD
Internal Medicine — Payments: $1,924